0001877971
Company
POMDOCTOR Ltd
Retail-Miscellaneous Retail · POM
ipo
trading
priced
Nasdaq
424B4
Filing Timeline
SEC EDGAR
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows CERT and confirms the priced prospectus.
Price $4.00 · 833,334 shares · Gross proceeds $20,000,016
Class A · Exchange Nasdaq · Ticker POM · Use of proceeds Proceeds will be used for general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class · Underwriters self-underwritten
2025-10-09 · 0001213900-25-097580
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2025-10-07 · 0001354457-25-000998
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows F-1/A and marks the registration effective.
2025-09-30 · 9999999995-25-003169
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2025-09-30 · 9999999995-25-003178
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Flags cayman_holding_company, foreign_private_issuer
2025-09-26 · 0001213900-25-092301
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Range $4.00 to $6.00 · 5,000,004 shares
Class A · Exchange Nasdaq Global Market · Ticker POM · 6 ADSs = 1 Class A share · Use of proceeds Proceeds will be used for general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class
2025-09-19 · 0001213900-25-089295
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Range $4.00 to $6.00 · 5,000,004 shares
Class A · Exchange Nasdaq Global Market · Ticker POM · Six ADSs represent one Class A ordinary share · Flags cayman_holding_company, vie_structure, dual_class
2025-08-28 · 0001213900-25-081521
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Range $4.00 to $6.00 · 5,000,004 shares
Class A Ordinary Shares · Exchange Nasdaq · Ticker POM · Use of proceeds for general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class
2025-08-05 · 0001213900-25-071951
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows 8-A12B and supplements the active offering with updated prospectus details.
Price $5.00 · Range $4.00 to $6.00 · 5,000,004 shares · Gross proceeds $25,000,000
Class A ordinary share · Exchange Nasdaq · Ticker POM · Over-allotment 750,000 · Use of proceeds 35% for supply chain stocking, 25% for expansion, 20% for working capital, 10% for research and development, and the remainder for general corporate purposes · Flags cayman_holding_company, vie_structure · Underwriters Joseph Stone Capital, LLC, Uphorizon, LLC
2025-08-04 · 0001213900-25-070844
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Range $4.00 to $6.00 · 5,000,004 shares
Class A Ordinary Shares · Exchange Nasdaq Global Market · Ticker POM · Six ADSs represent one Class A Ordinary Share · Flags cayman_holding_company, vie_structure, dual_class, foreign_private_issuer
2025-07-15 · 0001213900-25-064103
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows F-1/A and registers the class of securities for exchange listing.
2025-07-15 · 0001213900-25-064118
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Class A · Exchange Nasdaq Global Market · Ticker POM · Use of proceeds for general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class
2025-06-17 · 0001213900-25-054956
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
Class A · Exchange Nasdaq Global Market · Ticker POM · Use of proceeds general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class
2025-03-31 · 0001213900-25-026366
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
vote per share · Exchange Nasdaq · Ticker POM · Use of proceeds general corporate purposes · Flags cayman_holding_company, vie_structure, dual_class
2025-03-13 · 0001213900-25-023540
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-01-17 · 0001213900-25-004428
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2024-12-23 · 0001213900-24-111692
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2024-11-06 · 0001213900-24-094863
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
POMDOCTOR Ltd. is conducting an initial public offering (IPO) of American Depositary Shares (ADSs) representing Class A ordinary shares. The offering includes details on a dual-class share structure, with Class B shares holding 20 votes per share, and outlines risks related to its variable interest entity (VIE) structure, regulatory uncertainties in China, and potential impacts from U.S.-China regulatory tensions. The company anticipates listing on Nasdaq under the symbol 'POM' and highlights its reliance on contractual arrangements with its VIE for operations in China.
2024-05-02 · 0001213900-24-039185
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
POMDOCTOR Ltd. is conducting an initial public offering (IPO) of American Depositary Shares (ADSs) representing Class A ordinary shares. The company, a Cayman Islands holding company, operates through a variable interest entity (VIE) in China, with its primary business activities in digital health and medical technology. The IPO aims to list on the Nasdaq Global Market under the symbol 'POM'. The filing highlights risks related to the VIE structure, PRC regulatory environment, and dual-class share voting control, which could impact investor rights and company operations.
2023-12-22 · 0001213900-23-098227
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
POMDOCTOR Ltd. is conducting an initial public offering (IPO) of American Depositary Shares (ADSs), representing Class A ordinary shares. The company, a Cayman Islands holding company, operates in China through contractual arrangements with its variable interest entity (VIE), Guangzhou Qilekang Digital Health Medical Technology Co., Ltd. The IPO includes a dual-class share structure, with Class B shares holding 20 votes per share, granting significant control to existing shareholders. The ADSs are expected to be listed on Nasdaq, with an anticipated price range disclosed. The filing highlights risks related to the VIE structure, PRC regulatory environment, and cash transfer restrictions.
2023-09-13 · 0001213900-23-076248
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
POMDOCTOR Ltd. filed a DRS/A form for its initial public offering (IPO) of American Depositary Shares (ADSs), representing Class A ordinary shares. The company, a Cayman Islands holding company, operates through a variable interest entity (VIE) in China. The filing outlines the dual-class share structure, with Class B shares granting significant voting control to Mr. Zhenyang Shi and Ms. Li Xu. It highlights risks related to PRC regulations, VIE contractual arrangements, and potential U.S.-China regulatory tensions, including the Holding Foreign Companies Accountable Act (HFCAA). The IPO price range and listing on Nasdaq are anticipated.
2023-08-23 · 0001213900-23-070067
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
POMDOCTOR Ltd is conducting an initial public offering (IPO) of American Depositary Shares (ADSs) representing Class A ordinary shares. The company, a Cayman Islands holding company, operates in China through contractual arrangements with its variable interest entity (VIE), Guangzhou Qilekang Digital Health Medical Technology Co., Ltd. The IPO aims to list ADSs on Nasdaq under the symbol "POMD." The corporate structure includes Class A and Class B shares, with Class B shares holding 20 votes per share and convertible into Class A shares. The filing highlights risks related to PRC regulations, VIE contractual arrangements, and potential impacts from U.S. securities laws like the Holding Foreign Companies Accountable Act (HFCAA).
2023-07-18 · 0001213900-23-057741
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
POMDOCTOR Ltd, a Cayman Islands holding company, is conducting an initial public offering (IPO) of American Depositary Shares (ADSs) representing Class A ordinary shares. The company operates in China through contractual arrangements with its Variable Interest Entity (VIE), Guangzhou Qilekang Digital Health Medical Technology Co., Ltd., due to restrictions on direct foreign investment. The offering includes details on share structure, risk factors related to PRC regulations, and corporate governance. The IPO aims to list ADSs on a U.S. exchange, with proceeds intended for general corporate purposes.
2021-12-06 · 0001213900-21-063526
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
POMDOCTOR Ltd, a Cayman Islands holding company, is conducting an initial public offering (IPO) of American Depositary Shares (ADSs) representing Class A ordinary shares. The company operates in China through a variable interest entity (VIE) and focuses on online medical services for chronic diseases. The filing outlines the corporate structure, risks related to VIE arrangements, regulatory challenges in China, and the use of proceeds from the offering. The IPO is structured to list ADSs on a U.S. exchange, with underwriters including Tiger Brokers.
2021-09-30 · 0001213900-21-050832
Comparable Deals
2 comparable deals
Consumer DiscretionaryMicro (<$50M)self-underwrittenLast 18 months
Only 0 strict matches; expanded to 2 using nearest neighbors.
Recent News
No recent news stored for this issuer.